Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-083815
Filing Date
2020-03-24
Accepted
2020-03-24 16:15:35
Documents
2
Group Members
ARIX BIOSCIENCE HOLDINGS LTDMARK CHIN

Document Format Files

Seq Description Document Type Size
1 SC 13D d905770dsc13d.htm SC 13D 104022
2 EX-99.4 d905770dex994.htm EX-99.4 5303
  Complete submission text file 0001193125-20-083815.txt   110822
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Subject) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91465 | Film No.: 20738553
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13D